<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Opazo F</submitter><funding>European Research Council</funding><pagination>e251</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4877450</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4</volume><pubmed_abstract>Aptamers are valuable tools that provide great potential to develop cost-effective diagnostics and therapies in the biomedical field. Here, we report a novel DNA aptamer that folds into an unconventional G-quadruplex structure able to recognize and enter specifically into human Burkitt's lymphoma cells. We further optimized this aptamer to a highly versatile and stable minimized version. The minimized aptamer can be easily equipped with different functionalities like quantum dots, organic dyes, or even a second different aptamer domain yielding a bi-paratopic aptamer. Although the target molecule of the aptamer remains unknown, our microscopy and pharmacological studies revealed that the aptamer hijacks the clathrin-mediated endocytosis pathway for its cellular internalization. We conclude</pubmed_abstract><journal>Molecular therapy. Nucleic acids</journal><pubmed_title>Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer.</pubmed_title><pmcid>PMC4877450</pmcid><funding_grant_id>268776</funding_grant_id><pubmed_authors>Opazo F</pubmed_authors><pubmed_authors>Kjems J</pubmed_authors><pubmed_authors>Rohrbach F</pubmed_authors><pubmed_authors>Wengel J</pubmed_authors><pubmed_authors>Mayer G</pubmed_authors><pubmed_authors>Hansen L</pubmed_authors><pubmed_authors>Eiden L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer.</name><description>Aptamers are valuable tools that provide great potential to develop cost-effective diagnostics and therapies in the biomedical field. Here, we report a novel DNA aptamer that folds into an unconventional G-quadruplex structure able to recognize and enter specifically into human Burkitt's lymphoma cells. We further optimized this aptamer to a highly versatile and stable minimized version. The minimized aptamer can be easily equipped with different functionalities like quantum dots, organic dyes, or even a second different aptamer domain yielding a bi-paratopic aptamer. Although the target molecule of the aptamer remains unknown, our microscopy and pharmacological studies revealed that the aptamer hijacks the clathrin-mediated endocytosis pathway for its cellular internalization. We conclude</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Sep</publication><modification>2025-04-19T14:48:01.048Z</modification><creation>2019-03-27T02:14:22Z</creation></dates><accession>S-EPMC4877450</accession><cross_references><pubmed>26325628</pubmed><doi>10.1038/mtna.2015.25</doi></cross_references></HashMap>